Keynote: DRAGON project - COVID-19 Pandemic: where do we stand now? C. Brightling (Leicester, United Kingdom), W. Vos (Tongeren, Belgium)
|  |
Epidemiology of acute COVID-19 infection A. Torres Marti (Barcelona, Spain)
|  |
Epidemiology of Long COVID G. Rohde (Frankfurt, Germany)
|  |
Epidemiology of acute and long COVID in children A. Möller (Zurich, Switzerland)
|  |
Epidemiology - Roundtable discussion and Q&A
|  |
Pathophysiology of acute COVID-19 M. Shankar-Hari (Edinburgh, United Kingdom)
|  |
Pathophysiology of Long COVID K. Antoniou (Heraklion, Greece)
|  |
Pathophysiology of acute and long COVID in children F. Brinkmann (Bochum, Germany)
|  |
Pathophysiology - Roundtable discussion and Q&A
|  |
Management of acute COVID-19 N. Roche (Paris, France)
|  |
Management of Long COVID R. Evans (Leicester, United Kingdom)
|  |
Management of acute and long COVID in children C. Kosterink-Brackel (Voorburg, Netherlands)
|  |
Management - Roundtable discussion and Q&A
|  |
Workshop introduction and Q&A S. Wagers (Maasmechelen, Belgium)
|  |
Breakout group 1 K. Howard (Ann Arbor, USA), Rebecca Baker (Austin, USA)
|  |
Breakout group 3 P. Powell (Sheffield, United Kingdom)
|  |
Breakout group 4 J. Schofield (Southampton, United Kingdom)
|  |
Wrap-up and closing remarks S. Wagers (Maasmechelen, Belgium)
|  |